Procedural Complications and Long-Term Mortality in Complex Coronary Interventions
Recruiting
Observational Study
Complex Coronary Artery Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20,000 (estimated)
- Sponsor
- Istanbul Mehmet Akif Ersoy Educational and Training Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The relative risks for different non-fatal intraprocedural complications during complex percutaneous coronary intervention (PCI) on subsequent mortality have not been described. This study aimed to assess the association between non-fatal intraprocedural complications and late mortality after complex coronary PCI.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with complex coronary disease
* Aged 18-85 years
Exclusion Criteria:
* Patients diagnosed with cardiogenic shock
* Coronary lesions with non-complex features
* Percutaneous coronary intervention with a bare metal stent
* Patient life expectancy \<1 year
* Known rele…
Contacts
No contact information available.